Robert Andrew Berman, Chief Executive Officer at enVVeno Medical Corp (NVNO), bought 12,000 shares at $2.55 ($31K) on 2024-12-19, disclosed to the SEC on 2024-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| NVNO | BUY | 2021-11-18 | $16K | — | Filing → |
| HJLI | BUY | 2021-05-19 | $16K | — | Filing → |
| HJLI | BUY | 2019-04-17 | $25K | — | Filing → |